aurintricarboxylic acid has been researched along with celastrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Cavalloro, V; Collina, S; Kirchmair, J; Linciano, P; Listro, R; Martino, E; Rossi, D | 1 |
2 other study(ies) available for aurintricarboxylic acid and celastrol
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Tackling Antimicrobial Resistance with Small Molecules Targeting LsrK: Challenges and Opportunities.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Docking Simulation; Phosphotransferases (Alcohol Group Acceptor); Quorum Sensing; Small Molecule Libraries | 2020 |